Ibritumomab Tiuxetan and Prograf (Tacrolimus Capsules)
Determining the interaction of Ibritumomab Tiuxetan and Prograf (Tacrolimus Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: tacrolimus
Brand name: Prograf, Astagraf XL, Envarsus XR, Hecoria
Synonyms: Prograf
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Prograf (Tacrolimus Granules for Suspension)
- Ibritumomab Tiuxetan-Prograf (Tacrolimus Injection)
- Ibritumomab Tiuxetan-Prograf Intravenous
- Ibritumomab Tiuxetan-Prohance
- Ibritumomab Tiuxetan-ProHance Injection
- Ibritumomab Tiuxetan-Prohist LQ
- Prograf (Tacrolimus Capsules)-Ibrutinib
- Prograf (Tacrolimus Capsules)-Ibrutinib Capsules
- Prograf (Tacrolimus Capsules)-Ibrutinib Tablets
- Prograf (Tacrolimus Capsules)-Ibu
- Prograf (Tacrolimus Capsules)-IBU Tablets
- Prograf (Tacrolimus Capsules)-Ibu-2